期刊文献+

口服糖耐量试验中血糖及相关激素水平观察 被引量:1

Plasma Glucose and Related Hormone Levels During Oral Glucose Tolerance Test
下载PDF
导出
摘要 目的 研究口服糖耐量试验(OGTT)过程中胰岛素、胰高血糖素、生长抑素、瘦素对血糖的影响及相互关系。方法 选择我院内分泌门诊初诊者38人,在作OGTT的同时测定胰岛素、胰高血糖素、生长抑素和瘦素,分析这些激素水平与血糖浓度变化的关系,以及这些激素相互之间的关系。结果 在38人中,OGTT显示9人糖耐量正常,29例为糖尿病或糖耐量异常。与糖耐量正常组比较,糖耐量异常组患者的血糖值显著性增高,胰岛素峰值延后。两组的胰高血糖素均有分泌峰,但激素水平组间无差异。生长抑素和瘦素均无明显的峰值,组间也无差别。结论 在OGTT过程中,胰岛素和胰高血糖素随血糖的变化而变化,在血糖调节中起主要作用,而生长抑素与瘦素对维持血糖的稳定作用较小。 Objective To study the effects of insulin, glucagon , somatostatin and leptin in maintaining plasma glucose level during oral glucose tolerance test ( OGTT) and the relationship among these hormones. Methods Thirty - eight subjects from the endocrine clinic of our hospital were selected. During OGTT, plasma glucose , insulin, glucagon, somatostatin and leptin of these subjects were measured simultaneously, and the relationship between these hormones and plasma glucose was analyzed. Results Nine subjects had normal glucose tolerance and 29 subjects were diabetic or impaired in glucose tolerance. Compared with the normal glucose tolerance group, those in the abnormal glucose tolerance group had significantly higher plasma glucose and delayed insulin peak values. The glucagon levels of both groups increased initially and then decreased. No significant difference was found between the two groups. Somatostatin and leptin levels did not change significantly during the period and no difference existed between the two groups. Conclusion During OGTT, insulin and glucagon levels change with the plasma glucose concentration, and they may play a key role in maintaining glucose concentration. Somatostatin and leptin have fewer effects in glucose regulation.
出处 《上海第二医科大学学报》 CSCD 2003年第2期128-130,共3页 Acta Universitatis Medicinalis Secondae Shanghai
关键词 血糖 胰鸟素 胰高血糖素 生长抑素 瘦素 blood glucose insulin glucagon somatostatin leptin
  • 相关文献

参考文献9

  • 1Zhang Y, Proenca R, Maffei M, et al.Positional cloning of the mouse obese gene and its human homologue[J].Nature,1994,372:425-432.
  • 2陈名道.从瘦素到增食欲素——肥胖研究的新热点[J].中华内科杂志,1999,38(1):61-64. 被引量:48
  • 3陈名道,顾卫琼,唐金凤,李凤英,陈春荣,胡仁明,许曼音,陈家伦.口服糖耐量试验中血糖和胰岛素动态变化对瘦素的影响[J].中华内科杂志,1999,38(11):740-743. 被引量:20
  • 4Gin H, Rigalleau V. Postprandial hyperglycemia:postprandial hyperglycemia anddiabetes[J]. Diabetes Metab,2000,26:265-272.
  • 5Shan P, Vella A, Basu A, et al. Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus[J]. J Clin Endocrinol Metab,2000,85:4053-4059.
  • 6Carlsson A, Sundkvist G, Groop L, et鬭l. Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes(LADA)[J].J Clin Endocrinol Metab,2000,85:76-80.
  • 7Larsson H, Berglund G, Ahren B. Glucose modulation of insulin and glucagon secretion is altered in impaired glucose tolerance[J].J Clin Endocrinol Metab,1995,80:1778-1782.
  • 8Kumar U, Sasi R, Suresh S, et al. Subtype-selective expression of the five somatostatin receptors(hSSTR1-5) in humanpancreatic islet cells:a quantitative double-label immunohistochemical analysis[J].Diabetes,1999,48:77-82.
  • 9Atiya AW, Moldovan S, Adrian TE, et al. Intraislet somatostatin inhibits insulin(via a subtype-somatostatin receptor) but not islet amyloid polypeptide secretion in the isolated perfused human pancreas[J]. J Gastrointest Surg,1997,1:251-256.

二级参考文献12

  • 1胰岛素B细胞功能协作组.正常人馒头餐试验过程中血糖、胰岛素、C肽的研究[J].中华医学杂志,1982,62:643-647.
  • 2陈名道,中华内分泌代谢杂志,1998年,14卷,163页
  • 3贾伟平,中华内分泌代谢杂志,1998年,14卷,78页
  • 4Mounzih K,Endocrinology,1997年,138卷,1190页
  • 5Chehab F F,Science,1997年,275卷,88页
  • 6Zhang Y,Nature,1994年,372卷,425页
  • 7Chen M D,Chin Med J,1999年,112卷,801页
  • 8顾卫琼,中华内分泌代谢杂志,1999年,15卷,15页
  • 9陈名道,中华内科杂志,1999年,38卷,61页
  • 10胰岛素B 细胞功能协作组,中华医学杂志,1982年,62卷,643页

共引文献64

同被引文献11

  • 1Dunning BE, Poley JE, Ahrea B. Alpha cell function in health and disease:influence of glucagon-like peptide-1. Diabetologia, 2005,48:1700-1713.
  • 2史轶蘩.胰岛激素的生理生化//孙琦,王妲.协和内分泌和代谢学.北京:科学出版社,1999.
  • 3Mu J, J iang G, Brady E, et al. Chronic treatment with a glucagon receptor antagonist lowers glucose and moderately raises Circu- lating glucagon and glucagon-like peptide 1 without severe alpha cell hypertrophy in diet-induced obese mice. Diahetologia,2011,54 : 2381-2391.
  • 4Takeda Y, Fujita Y, Honjo J, et al. Reduction of both beta cell death and alpha cell proliferation by dipeptidyl peptidase-4 inhi- bition in a streptozotocin-indueed model of diabetes in mice. Di- abetologia, 2012,55 : 404-412.
  • 5Rosenstock J, Aguilar-Salinas C, Klein E, et al. Effect of saxa- gliptin monotherapy in treatment-nave patients with type 2 dia- betes. Curr Med Res Opin, 2009,25 : 2401-2411.
  • 6Henry RR, Smith SR, Schwantz SL, et al. Effects of saxagliptin on β-eell stimulation and insulin secretion in patients with type 2 diabetes. Diabetes Obes Metab, 2011,13 : 850-858.
  • 7Unger RH, Aguilar-Parada E, Muller WA, et al. Studies of pan- creatic alpha cell function in normal and diabetic subjects. J Clin Invest, 1970,49 : 837-848.
  • 8Dunning BE, Foley JE, Ahren B. Alpha cell function in health and disease: influence of glucagon-like peptide-1. Diabetologia, 2005,48 : 1700-1713.
  • 9Chideckel EW, Palmer J, Koerker DJ, et al. Somatostatin block- ade of acute and chronic stimuli of the endocrine pancreas and the consequences of this blockade on glucose homeostasis. J Clin Invest , 1975,55 : 754-762.
  • 10陈巨,陈重,邝建,杨华章.阿卡波糖对2型糖尿病患者胰高血糖素的影响[J].循证医学,2009,9(2):101-104. 被引量:12

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部